Rare diseases
Investigational molecules
Locations
Study on the Safety and Effectiveness of Opelconazole with Other Antifungal Treatments for Patients with Hard-to-Treat Lung Aspergillosis
AustriaStudy Comparing Anitocabtagene Autoleucel with Standard Treatment for Patients with Relapsed or Refractory Multiple Myeloma
AustriaStudy of inotuzumab ozogamicin and drug combination in adult patients with B-cell Acute Lymphoblastic Leukemia who have minimal residual disease before stem cell transplantation
ItalyLong-term safety and effectiveness study of pozelimab and cemdisiran combination treatment in adults with paroxysmal nocturnal hemoglobinuria (PNH)
GreeceStudy on the Effectiveness and Safety of Cyclosporine and Methotrexate for Children and Adolescents with Moderate to Severe Atopic Dermatitis
PolandStudy on the Effectiveness of Doravirine and Dolutegravir for People with HIV Switching Antiretroviral Therapy
ItalyStudy on the Safety and Effectiveness of Pozelimab and Cemdisiran for Adults with Paroxysmal Nocturnal Hemoglobinuria Not Recently Treated with Complement Inhibitors
GreeceStudy of Irinotecan with S1 or 5-Fluorouracil for Patients with Metastatic Pancreatic Cancer After Gemcitabine Treatment
AustriaStudy on the Effects of Intradermal IMO-2125 (Tilsotolimod) for Patients with Advanced Melanoma
The NetherlandsStudy on Iberdomide, Cyclophosphamide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma
The NetherlandsStudy on Istaroxime for Patients with Cardiogenic Shock Stage C
CzechiaStudy on the Effects of TTI-0102 for Patients with MELAS Syndrome
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
